Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesFebruary 24, 2026
FDA Issues Plausible Mechanism Pathway Draft Guidance to Spur Innovation for Individualized TherapiesFebruary 24, 2026
Microbiome FDA Issues Plausible Mechanism Pathway Draft Guidance to Spur Innovation for Individualized TherapiesBy adminFebruary 24, 20260 Robert F. Kennedy, Jr. opens the HHS briefing in Washington DC to unveil the agency’s draft guidance for rare disease…
